Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Cureus|June 16, 2025
Deucravacitinib Treatment for Psoriasis Complicated by Myelodysplastic Syndrome Without Exacerbation of the Underlying Hematologic Disorder: A Case ReportYoshihito Mima, Masako Yamamoto, Ken IozumiCureus|December 15, 2025
Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to DupilumabYoshihito Mima, Masako Yamamoto, Ken IozumiCureus|August 21, 2025
Pregabalin as a Potential Adjunct in the Management of Pruritus in Prurigo Nodularis: A Case ReportYoshihito Mima, Masako Yamamoto, Ken IozumiCureus|January 20, 2025
Green Nail in a Patient With Psoriasis Receiving DeucravacitinibYoshihito Mima, Tsutomu Ohtsuka, Yuta NorimatsuThe Journal of Dermatological Treatment|February 3, 2026
24-week real world outcomes of nemolizumab in patients with prurigo nodularisYoshihito Mima, Masako Yamamoto, Ken IozumiCureus|July 7, 2025
Tacrolimus Ophthalmic Suspension Can Be an Effective Treatment Option for Biologic-Induced Refractory ConjunctivitisYoshihito Mima, Masako Yamamoto, Ken IozumiThe Journal of Dermatological Treatment|June 20, 2026
Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasisYoshihito Mima, Masako Yamamoto, Ken IozumiCureus|October 2, 2025
Long-Lasting Seborrheic Dermatitis Associated With Human Immunodeficiency VirusYoshihito Mima, Masako Yamamoto, Akira Nonogaki, et al.Medical Mycology Case Reports|December 6, 2024
Onychomycosis with gray-green staining caused by <i>Fusarium</i> <i>solani</i>Yoshihito Mima, Masako Yamamoto, Koichi Makimura, et al.Clinical, Cosmetic and Investigational Dermatology|July 14, 2025
Deucravacitinib Improved Interstitial Pneumonia Along with KL-6 Reduction in a Patient with Psoriasis: A Case ReportYoshihito Mima, Tsutomu Ohtsuka, Norimichi Akiyama, et al.Pageof 4